Search - tctmd.com

Displaying 821 - 840 of 1457

Sort: Relevancy | Date

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

Case Presentations: The Issue: Introducing Two Aortic Stenosis Cases Which Might Invoke Different Approaches (Moderate and High Surgical Risk)

Presenter: Isaac George

October 29, 2013

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

News Industry News

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

Presentation TCT 2013

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

Safety and Durability of Angioplasty for Isolated Penile Artery Stenosis in Patients with Erectile Dysfunction: A First-in-Man Study

Presenter: Tzung-Dau Wang

October 28, 2013

Presentation TCT 2013

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

Presenter: Dominique Himbert

October 28, 2013

Presentation TCT 2013

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Joachim Schofer

October 28, 2013

Presentation TCT 2013

Case Presentation: TAVR in a Moderate Risk Aortic Stenosis Patient

Presenter: Alexey Protopopov

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Boston Scientific Receives CE Mark For Lotus™ Valve System

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

Presentation TCT 2013

Which Aortic Stenosis Patients Are Too Low-Risk for TAVR?

Presenter: Raj Makkar

October 27, 2013

Presentation TCT 2013

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

Presenter: Tim Lapp

October 27, 2013

Presentation TCT 2013

Which Aortic Stenosis Patients Are Too High-Risk for TAVR?

Presenter: Howard Herrmann

October 27, 2013

Presentation TCT 2013

My Crystal Ball: How Will the Aortic Stenosis Guidelines Change in the Next Decade with the Integration of TAVR?

Presenter: Robert Bonow

October 27, 2013

Presentation TCT 2013

Is Aortic Stenosis Undertreated in the Real World? Epidemiologic, Socioeconomic, and Disease Awareness Issues

Presenter: Patrick O'Gara

October 27, 2013

Presentation TCT 2013

Hemodynamics and Interactive Calculations for Aortic Stenosis using the “John Madden” Telestrator

Presenter: Jeff Davis

October 27, 2013

Advertisement

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Case Presentations: The Issue: Introducing Two Aortic Stenosis Cases Which Might Invoke Different Approaches (Moderate and High Surgical Risk)

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Epidemiology and Prognostic Impact of Mitral Regurgitation (and Why Does MR Take a Backseat to Aortic Stenosis?)

Safety and Durability of Angioplasty for Isolated Penile Artery Stenosis in Patients with Erectile Dysfunction: A First-in-Man Study

Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter Approaches and Outcomes

DISCOVER: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Case Presentation: TAVR in a Moderate Risk Aortic Stenosis Patient

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Boston Scientific Receives CE Mark For Lotus™ Valve System

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Which Aortic Stenosis Patients Are Too Low-Risk for TAVR?

Hemodynamics and Interactive Calculations for Mitral Stenosis and Mitral Regurgitation using the “John Madden” Telestrator

Which Aortic Stenosis Patients Are Too High-Risk for TAVR?

My Crystal Ball: How Will the Aortic Stenosis Guidelines Change in the Next Decade with the Integration of TAVR?

Is Aortic Stenosis Undertreated in the Real World? Epidemiologic, Socioeconomic, and Disease Awareness Issues

Hemodynamics and Interactive Calculations for Aortic Stenosis using the “John Madden” Telestrator

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content